Surgical Science Sweden AB (publ) (FRA:4P41)

Market Cap	157.21M -79.5%
Revenue (ttm)	91.70M +12.2%
Net Income	6.17M -49.2%
EPS	0.12 -49.2%
Shares Out	n/a
PE Ratio	25.46
Forward PE	14.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	410
Average Volume	21
Open	2.700
Previous Close	2.640
Day's Range	2.700 - 3.084
52-Week Range	2.230 - 15.350
Beta	n/a
RSI	67.46
Earnings Date	Feb 19, 2026

About FRA:4P41

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnosti...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 328
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4P41

Financial Performance

In 2025, FRA:4P41's revenue was 992.34 million, an increase of 12.25% compared to the previous year's 884.09 million. Earnings were 66.82 million, a decrease of -49.24%.

Financial numbers in SEK